Skariyachan Sinosh, Garka Shruthi, Puttaswamy Sushmitha, Shanbhogue Shobitha, Devaraju Raksha, Narayanappa Rajeswari
R & D Centre, Department of Biotechnology, Dayananda Sagar College of Engineering, Bangalore, Karnataka, 560078, India.
Environ Monit Assess. 2017 Jun;189(6):283. doi: 10.1007/s10661-017-5999-y. Epub 2017 May 23.
Assessment of the therapeutic potential of secondary metabolite producing microorganisms from the marine coastal areas imparts scope and application in the field of environmental monitoring. The present study aims to screen metabolites with antibacterial potential from actionbacteria associated with marine sediments collected from south coastal regions of Karnataka, India. The actinobacteria were isolated and characterized from marine sediments by standard protocol. The metabolites were extracted, and antibacterial potential was analyzed against eight hospital associated bacteria. The selected metabolites were partially characterized by proximate analysis, SDS-PAGE, and FTIR-spectroscopy. The antibiogram of the test clinical isolates revealed that they were emerged as multidrug-resistant strains (P ≤ 0.05). Among six actinobacteria (IS1-1S6) screened, 100 μl metabolite from IS1 showed significant antibacterial activities against all the clinical isolates except Pseudomonas aeruginosa. IS2 demonstrated antimicrobial potential towards Proteus mirabilis, Streptococcus pyogenes, and Escherichia coli. The metabolite from IS3 showed activity against Strep. pyogenes and E. coli. The metabolites from IS4, IS5, and IS6 exhibited antimicrobial activities against Ps. aeruginosa (P ≤ 0.05). The two metabolites that depicted highest antibacterial activities against the test strains were suggested to be antimicrobial peptides with low molecular weight. These isolates were characterized and designated as Streptomyces sp. strain mangaluru01 and Streptomyces sp. mangaloreK01 by 16S ribosomal DNA (rDNA) sequencing. This study suggests that south coastal regions of Karnataka, India, are one of the richest sources of antibacterial metabolites producing actinobacteria and monitoring of these regions for therapeutic intervention plays profound role in healthcare management.
评估来自海洋沿海地区的产生次生代谢产物的微生物的治疗潜力,为环境监测领域带来了应用范围和前景。本研究旨在从印度卡纳塔克邦南部沿海地区采集的海洋沉积物相关放线菌中筛选具有抗菌潜力的代谢产物。通过标准方案从海洋沉积物中分离并鉴定放线菌。提取代谢产物,并分析其对八种医院相关细菌的抗菌潜力。通过近似分析、SDS-PAGE和傅里叶变换红外光谱对所选代谢产物进行部分表征。测试临床分离株的抗菌谱显示它们已成为多重耐药菌株(P≤0.05)。在筛选的六种放线菌(IS1-1S6)中,IS1的100μl代谢产物对除铜绿假单胞菌外的所有临床分离株均表现出显著的抗菌活性。IS2对奇异变形杆菌、化脓性链球菌和大肠杆菌具有抗菌潜力。IS3的代谢产物对化脓性链球菌和大肠杆菌有活性。IS4、IS5和IS6的代谢产物对铜绿假单胞菌表现出抗菌活性(P≤0.05)。对测试菌株表现出最高抗菌活性的两种代谢产物被认为是低分子量抗菌肽。通过16S核糖体DNA(rDNA)测序对这些分离株进行表征并命名为链霉菌属菌株芒格洛尔01和链霉菌属芒格洛尔K01。本研究表明,印度卡纳塔克邦南部沿海地区是产生抗菌代谢产物的放线菌的最丰富来源之一,对这些地区进行治疗干预监测在医疗管理中发挥着重要作用。